Integrative Analysis of HNF1B mRNA in Human Cancers Based on Data Mining

Int J Med Sci. 2020 Oct 18;17(18):2895-2904. doi: 10.7150/ijms.51213. eCollection 2020.

Abstract

Cancer incidence is rapidly growing, and cancer is the leading cause of death worldwide in the 21st century. Hepatocyte nuclear factor 1B (HNF1B) is a transcription factor that involves the growth and development of multiple organs. The aim of this study was to explore the significance of HNF1B in human cancer by an integrative analysis of online databases. The UALCAN database, cBio cancer genomics portal, Cancer Regulome tools, Kaplan-Meier plotter and Tumor IMmune Estimation Resource (TIMER) website were used to perform the corresponding analysis. The results showed that HNF1B is dysregulated in various cancers and associated with the differential overall survival of cancer patients. HNF1B showed many mutation forms and high mutation levels in different cancer types. In addition, we found that HNF1B interacted with different genes in multiple aspects. Moreover, HNF1B expression is associated with many immune cell infiltration levels and influences the prognostic prediction of immune cells in some kinds of cancers. In conclusion, HNF1B plays a significant role in cancer and may be a potential target for cancer immunotherapy.

Keywords: HNF1B; biomarker; cancer; immunotherapy.

MeSH terms

  • Biomarkers, Tumor / genetics*
  • Biomarkers, Tumor / metabolism
  • Data Mining
  • Datasets as Topic
  • Gene Expression Regulation, Neoplastic
  • Hepatocyte Nuclear Factor 1-beta / genetics*
  • Humans
  • Kaplan-Meier Estimate
  • Mutation
  • Neoplasms / genetics*
  • Neoplasms / immunology
  • Neoplasms / mortality
  • Neoplasms / pathology
  • Prognosis
  • RNA, Messenger / metabolism
  • Tumor Microenvironment / genetics
  • Tumor Microenvironment / immunology

Substances

  • Biomarkers, Tumor
  • HNF1B protein, human
  • RNA, Messenger
  • Hepatocyte Nuclear Factor 1-beta